All Search Results
News Releases
May 14, 2026, 08:00 ET Rice Biotech Launch Pad to Sponsor 2nd Edition of the BioElectronic Therapeutics (BETx) Event hosted by the Rice Global Paris Center in June
Capital Strategies for Scaling Bioelectronics InnovationNext Generation Neuroelectronic InterfacesThe Intersection of Synthetic Biology and BioelectronicsHybrid Bioelectronic Systems: Integrating Living Materials with DevicesAdvanced Bioelectronic Sensing: From
More news about: Rice University
May 13, 2026, 08:04 ET ERS Genomics and Aurigene Sign CRISPR/Cas9 License Agreement to Advance Precision Genome Editing in Drug Discovery
cell lines and animal models for drug screening, bioproduction of antibodies and therapeutic proteins, animal and agricultural biotechnology, synthetic biology, including production of enzymes, food ingredients, and bio-based chemicals.Current ERS licensees include GSK, Merck, Bayer, Thermo Fisher
More news about: ERS Genomics
May 12, 2026, 05:55 ET ATUM's New Lock-In™ Platform Solves Bispecific Mispairing
research organization (CRO) providing services for gene design, protein engineering, and cell line development. By combining machine learning, synthetic biology, and proprietary expression technologies, ATUM helps partners worldwide transform digital sequences into clinical reality. ATUM is headquartered
More news about: ATUM
May 11, 2026, 13:33 ET DNA Synthesis Market to Reach $30.4 billion, Globally, by 2035 at 18.2% CAGR: Allied Market Research
strong adoption across pharmaceutical and biotechnology companies, academic and research institutes, contract research organizations (CROs), and synthetic biology firms due to its critical role in enabling advanced genetic research and biopharmaceutical development.PORTLAND,
More news about: Allied Market Research
May 11, 2026, 12:41 ET DNA Polymerase Market to Reach USD 725.8 Million by 2035 as Molecular Diagnostics and High-Fidelity Enzymes Accelerate Precision Genomics
become foundational tools in modern genomics, enabling critical applications such as PCR-based diagnostics, gene sequencing, forensic analysis, synthetic biology, and gene-editing workflows. The increasing prevalence of infectious diseases, genetic disorders, and cancer is significantly amplifying demand
More news about: Future Market Insights
